Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Stifel Financial Corp (SF)

Stifel Financial Corp (SF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Why Penumbra Stock Zoomed Nearly 5% Higher Today

The company might just be the right kind of business operating at the right time in history.

SF : 89.98 (+0.44%)
PEN : 195.58 (+4.55%)
Why Relay Therapeutics Plummeted by Nearly 14% Today

Investors weren't happy with the company's latest effort at capital-raising.

GS : 484.58 (-0.17%)
BAC : 39.62 (+0.18%)
SF : 89.98 (+0.44%)
RLAY : 7.58 (-0.26%)
Here's Why Birkenstock Stock Dropped Nearly 16% Last Month

When valuations are high, even little things can lead to disappointment.

SF : 89.98 (+0.44%)
BIRK : 48.24 (unch)
Are Wall Street Analysts Predicting Fastenal Stock Will Climb or Sink?

Fastenal has underperformed the broader market over the past year, and Wall Street analysts remain skeptical about the stock’s prospects.

FAST : 70.47 (-0.17%)
$SPX : 5,618.26 (-0.29%)
XLI : 131.85 (-0.08%)
SF : 89.98 (+0.44%)
Iovance Biotherapeutics Attracted a Downgrade. Is It Time to Sell?

Find out how concerned investors should be about setbacks for this company's revolutionary new cancer therapies.

MRK : 118.64 (+0.30%)
PIPR : 275.37 (+0.42%)
SF : 89.98 (+0.44%)
IOVA : 10.17 (-2.40%)
Stifel: Q2 Earnings Snapshot

Stifel: Q2 Earnings Snapshot

SF : 89.98 (+0.44%)
Stifel: Q1 Earnings Snapshot

Stifel: Q1 Earnings Snapshot

SF : 89.98 (+0.44%)
Why Summit Therapeutics Stock Crushed the Market This Week

The company was a standout in the biotech field, rising by nearly 23% over the period.

SF : 89.98 (+0.44%)
SMMT : 24.56 (-6.33%)
Why Viking Therapeutics Stock Was Rocketing Higher This Week

Good news from the lab and subsequent price target lifts by analysts put some zip into the company's shares.

SF : 89.98 (+0.44%)
OPY : 50.09 (-1.03%)
VKTX : 64.45 (+2.40%)
Why Lucid Stock Is Soaring Today

Lucid is receiving another major injection of capital.

LCID : 3.64 (-3.70%)
SF : 89.98 (+0.44%)

Barchart Exclusives

3 Top Dividend Stocks to Buy This September
After today's jumbo rate cut from the Fed, here are three dividend stocks to bolster your portfolio. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar